Label-free detection of cardiac troponin-I with packaged thin-walled microbubble resonators

J Biophotonics. 2022 Oct;15(10):e202200151. doi: 10.1002/jbio.202200151. Epub 2022 Jul 9.

Abstract

The measurement of cardiac troponin-I (cTnI) is widely used for diagnosing acute myocardial infarction (AMI) diseases because of its myocardial specificity. Packaged microbubble resonators with thin wall are utilized for label-free and specific detection of cTnI based on whispering gallery mode (WGM). This packaged structure can provide a good protection for the biosensor, improve the anti-interference ability of the sensor and reduce the system noise. The theoretical detection limit of the biosensors for cTnI in phosphate buffer saline (PBS) is 0.4 ag mL-1 (0.02 aM ). Furthermore, we demonstrated that the biosensors can be used to detect cTnI molecules in simulated serum and the theoretical detection limit is also 0.4 ag mL-1 (0.02 aM ). These results are much far below the clinical cut-off value and show a huge application potential for the detection of cardiac biomarkers of AMI.

Keywords: label-free biosensors; microbubble resonators; whispering gallery modes.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Biomarkers
  • Biosensing Techniques* / methods
  • Humans
  • Microbubbles
  • Myocardial Infarction* / diagnostic imaging
  • Phosphates
  • Troponin I

Substances

  • Biomarkers
  • Phosphates
  • Troponin I